The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2007, 179, 869-877
Copyright © 2007 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tomizawa, T.
Right arrow Articles by Matozaki, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tomizawa, T.
Right arrow Articles by Matozaki, T.

Resistance to Experimental Autoimmune Encephalomyelitis and Impaired T Cell Priming by Dendritic Cells in Src Homology 2 Domain-Containing Protein Tyrosine Phosphatase Substrate-1 Mutant Mice1

Takeshi Tomizawa2,*, Yuka Kaneko2,{dagger},{ddagger}, Yoriaki Kaneko3,*, Yasuyuki Saito*, Hiroshi Ohnishi{dagger}, Jun Okajo*, Chie Okuzawa*, Tomomi Ishikawa-Sekigami*, Yoji Murata{dagger}, Hideki Okazawa{dagger}, Koichi Okamoto{ddagger}, Yoshihisa Nojima* and Takashi Matozaki3,{dagger}

* Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine, Gunma, Japan; {dagger} Laboratory of Biosignal Sciences, Institute for Molecular and Cellular Regulation, Gunma University, Gunma, Japan; and {ddagger} Department of Neurology, Gunma University Graduate School of Medicine, Gunma, Japan

Src homology 2 domain-containing protein tyrosine phosphatase (SHP) substrate-1 (SHPS-1) is a transmembrane protein that binds the protein tyrosine phosphatases SHP-1 and SHP-2 through its cytoplasmic region and is expressed on the surface of CD11c+ dendritic cells (DCs) and macrophages. In this study, we show that mice that express a mutant form of SHPS-1 lacking most of the cytoplasmic region are resistant to experimental autoimmune encephalomyelitis (EAE) in response to immunization with a peptide derived from myelin oligodendrocyte glycoprotein (MOG (35–55)). The MOG (35–55)-induced proliferation of, and production of IFN-{gamma}, IL-2, and IL-17, by T cells from immunized SHPS-1 mutant mice were reduced compared with those apparent for wild-type cells. The abilities of splenic DCs from mutant mice to stimulate an allogenic MLR and to prime Ag-specific T cells were reduced. Both IL-12-stimulated and TLR-dependent cytokine production by DCs of mutant mice were also impaired. Finally, SHPS-1 mutant mice were resistant to induction of EAE by adoptive transfer of MOG (35–55)-specific T cells. These results show that SHPS-1 on DCs is essential for priming of naive T cells and the development of EAE. SHPS-1 is thus a potential therapeutic target in inflammatory disorders of the CNS and other autoimmune diseases.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas Cancer, a Grant-in-Aid for Scientific Research (B) and (C), a grant of Initiatives for Attractive Education in Graduate Schools, and a grant of the 21st Century Center of Excellence Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.

2 T.T., and Yu.K. contributed equally to this work.

3 Address correspondence and reprint requests to Dr. Takashi Matozaki, Laboratory of Biosignal Sciences, Institute for Molecular and Cellular Regulation, Gunma University, 3-39-15 Showa-Machi, Maebashi, Gunma 371-8512, Japan; E-mail address: matozaki{at}showa.gunma-u.ac.jp or Dr. Yoriaki Kaneko, Department of Clinical Science, Gunma University, Graduate School of Medicine, 3-39-22 Showa-Machi, Maebashi, Gunma 371-8512, Japan; E-mail address: ykaneko{at}showa.gunma-u.ac.jp

4 Abbreviations used in this paper: DC, dendritic cell; BMDC, DC derived from bone marrow; EAE, experimental autoimmune encephalomyelitis; LN, lymph node; MOG, myelin oligodendrocyte glycoprotein; ODN, oligodeoxynucleotide; SHP, Src homology 2 domain-containing protein tyrosine phosphatase; SHPS-1, SHP substrate-1; WT, wild type.




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
A. Reinhold, S. Reimann, D. Reinhold, B. Schraven, and M. Togni
Expression of SKAP-HOM in DCs is required for an optimal immune response in vivo
J. Leukoc. Biol., July 1, 2009; 86(1): 61 - 71.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Kobayashi, H. Ohnishi, H. Okazawa, Y. Murata, Y. Hayashi, H. Kobayashi, T. Kitamura, and T. Matozaki
Expression of Src Homology 2 Domain-Containing Protein Tyrosine Phosphatase Substrate-1 in Pancreatic {beta}-Cells and Its Role in Promotion of Insulin Secretion and Protection against Diabetes
Endocrinology, November 1, 2008; 149(11): 5662 - 5669.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Kusakari, H. Ohnishi, F.-J. Jin, Y. Kaneko, T. Murata, Y. Murata, H. Okazawa, and T. Matozaki
Trans-endocytosis of CD47 and SHPS-1 and its role in regulation of the CD47-SHPS-1 system
J. Cell Sci., April 15, 2008; 121(8): 1213 - 1223.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
A. Miyake, Y. Murata, H. Okazawa, H. Ikeda, Y. Niwayama, H. Ohnishi, Y. Hirata, and T. Matozaki
Negative regulation by SHPS-1 of Toll-like receptor-dependent proinflammatory cytokine production in macrophages.
Genes Cells, February 1, 2008; 13(2): 209 - 219.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.